The Current Ratio as of December 2025 (TTM) for Guobang Pharma Ltd. (605507.SS) is 3.20

According to Guobang Pharma Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 3.20. This represents a change of 19.47% compared to the average of 2.68 of the last 4 quarters.

Guobang Pharma Ltd. (605507.SS) Historical Current Ratio (quarterly & annually)

How has 605507.SS Current Ratio performed in the past?

The mean historical Current Ratio of Guobang Pharma Ltd. over the last ten years is 2.18. The current 3.20 Current Ratio has changed 14.60% with respect to the historical average. Over the past ten years (40 quarters), 605507.SS's Current Ratio was at its highest in in the December 2021 quarter at 3.96. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Guobang Pharma Ltd. (605507.SS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Guobang Pharma Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Guobang Pharma Ltd. (605507.SS) Average Current Ratio

How has 605507.SS Current Ratio performed in the past?

The current Current Ratio of Guobang Pharma Ltd. (605507.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Guobang Pharma Ltd. (605507.SS) Current Ratio vs. Peers

How is 605507.SS’s Current Ratio compared to its peers?

Guobang Pharma Ltd.’s Current Ratio is greater than Henan Lingrui Pharmaceutical Co., Ltd. (1.08), less than Mayinglong Pharmaceutical Group Co., Ltd. (5.02), greater than Xiamen Kingdomway Group Company (2.64), greater than Zhejiang Hisun Pharmaceutical Co., Ltd. (0.95), greater than Jiang Zhong Pharmaceutical Co.,Ltd (1.58), less than Shanghai Shyndec Pharmaceutical Co., Ltd. (3.21), less than Changzhou Qianhong Biopharma CO.,LTD (11.83), greater than Zhejiang Medicine Co., Ltd. (2.79), greater than Tibet Rhodiola Pharmaceutical Holding Co. (3.02), greater than Shenzhen Chipscreen Biosciences Co., Ltd. (1.87),

Build a custom stock screener for Guobang Pharma Ltd. (605507.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Guobang Pharma Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Guobang Pharma Ltd. (605507.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Guobang Pharma Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.